DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 52-Week Low - Should You Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s share price hit a new 52-week low on Monday . The company traded as low as $14.61 and last traded at $14.78, with a volume of 150672 shares. The stock had previously closed at $14.93.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Morgan Stanley cut their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research report on Tuesday, December 17th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $23.33.

DENTSPLY SIRONA Stock Down 0.3 %

The firm has a market cap of $2.70 billion, a price-to-earnings ratio of -6.56, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The stock's 50 day moving average is $17.25 and its 200 day moving average is $19.89. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.71%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.52% of the company's stock.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock worth $383,078,000 after buying an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC grew its holdings in shares of DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock worth $275,218,000 after acquiring an additional 348,532 shares during the last quarter. Nuance Investments LLC increased its stake in DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after buying an additional 1,975,404 shares during the period. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock worth $219,018,000 after acquiring an additional 314,343 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.